Discrepancies between Office and Ambulatory Blood Pressure: Clinical Implications

被引:31
作者
Banegas, Jose R. [2 ,3 ]
Messerli, Franz H. [4 ]
Waeber, Bernard [5 ,6 ]
Rodriguez-Artalejo, Fernando [2 ,3 ]
de la Sierra, Alex [7 ]
Segura, Julian [1 ]
Roca-Cusachs, Alex [8 ]
Aranda, Pedro [9 ]
Ruilope, Luis M. [1 ]
机构
[1] Doce Octubre Hosp, Hypertens Unit, Madrid 28041, Spain
[2] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, E-28049 Madrid, Spain
[3] CIBERESP, Barcelona, Spain
[4] Columbia Univ, St Lukes Roosevelt Hosp, Coll Phys & Surg, Div Cardiol, New York, NY USA
[5] CHU Vaudois, Div Clin Pathophysiol, Lausanne, Switzerland
[6] Univ Lausanne, CH-1015 Lausanne, Switzerland
[7] Hosp Clin Barcelona, Hypertens Unit, Barcelona, Spain
[8] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Internal Med, Hypertens Unit, E-08193 Barcelona, Spain
[9] Hosp Reg Univ Carlos Haya, Dept Nephrol, Malaga, Spain
关键词
Ambulatory blood pressure; Antihypertensive therapy; Blood pressure control; Clinical trials; Office blood pressure; Treatment goals; HIGH CARDIOVASCULAR RISK; HYPERTENSIVE PATIENTS; MORTALITY; REDUCTION; DISEASE; EVENTS; INTERVENTION; POPULATION; AMLODIPINE; PREVENTION;
D O I
10.1016/j.amjmed.2009.05.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Recent trials have documented no benefit from small reductions in blood pressure measured in the clinical office. However, ambulatory blood pressure is a better predictor of cardiovascular events than office-based blood pressure. We assessed control of ambulatory blood pressure in treated hypertensive patients at high cardiovascular risk. METHODS: We selected 4729 patients from the Spanish Ambulatory Blood Pressure Monitoring Registry. Patients were aged >= 55 years and presented with at least one of the following co-morbidities: coronary heart disease, stroke, and diabetes with end-organ damage. An average of 2 measures of blood pressure in the office was used for analyses. Also, 24-hour ambulatory blood pressure was recorded at 20-minute intervals with a SpaceLabs 90207 device. RESULTS: Patients had a mean age of 69.6 (+/-8.2) years, and 60.8% of them were male. Average time from the diagnosis of hypertension to recruitment into the Registry was 10.9 (+/-8.4) years. Mean blood pressure in the office was 152.3/82.3 mm Hg, and mean 24-hour ambulatory blood pressure was 133.3/72.4 mm Hg. About 60% of patients with an office-pressure of 130-139/85-89 mm Hg, 42.4% with office-pressure of 140-159/90-99 mm Hg, and 23.3% with office-pressure >= 160/100 mm Hg were actually normotensive, according to 24-hour ambulatory blood pressure criteria (<130/80 mm Hg). CONCLUSION: We suggest that the lack of benefit of antihypertensive therapy in some trials may partly be due to some patients having normal pressure at trial baseline. Ambulatory monitoring of blood pressure may allow for a better assessment of trial eligibility. (C) 2009 Elsevier Inc. All rights reserved. The American Journal of Medicine (2009) 122, 1136-1141
引用
收藏
页码:1136 / 1141
页数:6
相关论文
共 28 条
[1]  
*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
[2]   Effectiveness of blood pressure control outside the medical setting [J].
Banegas, Jose R. ;
Segura, Julian ;
Sobrino, Javier ;
Rodriguez-Artalejo, Fernando ;
de la Sierra, Alejandro ;
de la Cruz, Juan J. ;
Gorostidi, Manuel ;
Sarria, Antonio ;
Ruilope, Luis M. .
HYPERTENSION, 2007, 49 (01) :62-68
[3]   Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [J].
Brown, MJ ;
Palmer, CR ;
Castaigne, A ;
de Leeuw, PW ;
Mancia, G ;
Rosenthal, T ;
Ruilope, LM .
LANCET, 2000, 356 (9227) :366-372
[4]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[5]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[6]   Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial [J].
Dahlöf, B ;
Sever, PS ;
Poulter, NR ;
Wedel, H ;
Beevers, DG ;
Caulfield, M ;
Collins, R ;
Kjeldsen, SE ;
Kristinsson, A ;
McInnes, GT ;
Mehlsen, J ;
Nieminen, M ;
O'Brien, E ;
Östergren, J .
LANCET, 2005, 366 (9489) :895-906
[7]   Superiority of ambulatory over clinic blood pressure measurement in predicting mortality - The Dublin Outcome Study [J].
Dolan, E ;
Stanton, A ;
Thijs, L ;
Hinedi, K ;
Atkins, N ;
McClory, S ;
Den Hond, E ;
McCormack, P ;
Staessen, JA ;
O'Brien, E .
HYPERTENSION, 2005, 46 (01) :156-161
[8]   Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk:: a cross-sectional analysis of a 20,000-patient database in Spain [J].
Gorostidi, Manuel ;
Sobrino, Javier ;
Segura, Julian ;
Sierra, Cristina ;
de la Sierra, Alex ;
del Rey, Raquel Hernandez ;
Vinyoles, Ernest ;
Galceran, Josep M. ;
Lopez-Eady, Maria D. ;
Marin, Rafael ;
Banegas, Jose R. ;
Sarria, Antonio ;
Coca, Antonio ;
Ruilope, Luis M. .
JOURNAL OF HYPERTENSION, 2007, 25 (05) :977-984
[9]   Ambulatory blood pressure and mortality - A population-based study [J].
Hansen, TW ;
Jeppesen, J ;
Rasmussen, S ;
Ibsen, H ;
Torp-Pedersen, C .
HYPERTENSION, 2005, 45 (04) :499-504
[10]   Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial [J].
Julius, S ;
Kjeldsen, SE ;
Weber, M ;
Brunner, HR ;
Ekman, S ;
Hansson, L ;
Hua, TS ;
Laragh, J ;
McInnes, GT ;
Mitchell, L ;
Plat, F ;
Schork, A ;
Smith, B ;
Zanchetti, A .
LANCET, 2004, 363 (9426) :2022-2031